BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33933681)

  • 1. HLA Class II Presentation Is Specifically Altered at Elevated Temperatures in the B-Lymphoblastic Cell Line JY.
    Demmers LC; Wu W; Heck AJR
    Mol Cell Proteomics; 2021; 20():100089. PubMed ID: 33933681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
    Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
    Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells.
    van Luijn MM; van de Loosdrecht AA; Lampen MH; van Veelen PA; Zevenbergen A; Kester MG; de Ru AH; Ossenkoppele GJ; van Hall T; van Ham SM
    PLoS One; 2012; 7(4):e34649. PubMed ID: 22563374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO.
    van Ham M; van Lith M; Lillemeier B; Tjin E; Grüneberg U; Rahman D; Pastoors L; van Meijgaarden K; Roucard C; Trowsdale J; Ottenhoff T; Pappin D; Neefjes J
    J Exp Med; 2000 Apr; 191(7):1127-36. PubMed ID: 10748231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired antigen presentation by murine I-Ad class II MHC molecules expressed in normal and HLA-DM-defective human B cell lines.
    Weenink S; Averdunk H; Boston T; Boswarva V; Guery JC; Adorini L; Mellins E; McCluskey J; Gautam AM
    Int Immunol; 1997 Jun; 9(6):889-96. PubMed ID: 9199972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins.
    Harris PE; Maffei A; Colovai AI; Kinne J; Tugulea S; Suciu-Foca N
    Blood; 1996 Jun; 87(12):5104-12. PubMed ID: 8652823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Autoimmunity-Related Gene
    Rijvers L; Melief MJ; van Langelaar J; van der Vuurst de Vries RM; Wierenga-Wolf AF; Koetzier SC; Priatel JJ; Jorritsma T; van Ham SM; Hintzen RQ; van Luijn MM
    J Immunol; 2020 Aug; 205(4):945-956. PubMed ID: 32641384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.
    Chong C; Marino F; Pak H; Racle J; Daniel RT; Müller M; Gfeller D; Coukos G; Bassani-Sternberg M
    Mol Cell Proteomics; 2018 Mar; 17(3):533-548. PubMed ID: 29242379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines.
    Riberdy JM; Avva RR; Geuze HJ; Cresswell P
    J Cell Biol; 1994 Jun; 125(6):1225-37. PubMed ID: 8207055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation by HLA-DO of MHC class II-restricted antigen processing.
    Denzin LK; Sant'Angelo DB; Hammond C; Surman MJ; Cresswell P
    Science; 1997 Oct; 278(5335):106-9. PubMed ID: 9311912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
    Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
    J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
    Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
    J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.
    van Ham SM; Grüneberg U; Malcherek G; Bröker I; Melms A; Trowsdale J
    J Exp Med; 1996 Nov; 184(5):2019-24. PubMed ID: 8920889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.
    van Luijn MM; Chamuleau ME; Ressing ME; Wiertz EJ; Ostrand-Rosenberg S; Souwer Y; Zevenbergen A; Ossenkoppele GJ; van de Loosdrecht AA; van Ham SM
    Cancer Immunol Immunother; 2010 Dec; 59(12):1825-38. PubMed ID: 20820776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry.
    Lorente E; Marcilla M; de la Sota PG; Quijada-Freire A; Mir C; López D
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.
    SenGupta D; Norris PJ; Suscovich TJ; Hassan-Zahraee M; Moffett HF; Trocha A; Draenert R; Goulder PJ; Binder RJ; Levey DL; Walker BD; Srivastava PK; Brander C
    J Immunol; 2004 Aug; 173(3):1987-93. PubMed ID: 15265933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.